Cite
HARVARD Citation
Obermann, E. et al. (2009). BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma. Journal of clinical pathology. 62 (10), pp. 903-907. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Obermann, E. et al. (2009). BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma. Journal of clinical pathology. 62 (10), pp. 903-907. [Online].